Rosuvastatin

Abbreviation
ZD-4522
Disease(s)
Diabetes
Patents oppositions filed in
Argentina

This drug is missing the following documents, can you help us by contributing something?

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
Argentina25-11-2002CILFAPre-GrantOtherP000100408View/Comment
Argentina19-12-2002CILFAPre-GrantSalts and OthersP000104057View/Comment
Argentina30-01-2003CILFAPre-GrantFormulationsP000104058View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top

Prior Art

This table lists related prior art used if a patent opposition has been filed on one or more of the patents.

TitleAuthorName of publicationPublishing dateRelated toRelated patent applicationMore info
EP0521471SHIONOGI & CO [JP]European Patent Office07-01-1993NoveltyP000100408View/Comment
Synthesis and biological activity of methanesulphonamide pyrimidine and N-methanesulphonyl pyrrole-sustituted 3,5-dihydroxy-6-heptanoates, a novel series of HMG-CoA reductasa inhibitorsMasamichi Watanabe et alBIOORGANIC. MED. CHEM. Vol. 5, Nº2, pages 473-474.01-01-1997NoveltyP000100408
ZD-4522 ; Hypolipidemic HMG-CoA reductasa inhibitorGRAUL,A et alDRUG of the FUTURE vol. 24, nº5, pages 511-51301-01-1999NoveltyP000100408, P000104057, P000104058
The role of HMG-CoA reductasa inhibitors in the treatment of Hyperlipidemia: a review of fluvastatinDESLYPERE JEAN PAUL CURRENT THERAPEUTIC RESEARCH VOL. 56, issue 2, pages 111-12801-02-1995Inventive StepP000100408
Non-lipid-related effects of HMG-CoA reductase inhibitorsCORSINI, A et alATHEROSCLEROSIS vol.115, page S136.01-06-1995Inventive StepP000100408
Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activityPazzucconi, F et alAtherosclerosis vol. 117, issue 2, pages 189-19801-10-1995Inventive StepP000100408
WO9723200KOWA CO [JP]; NISSAN CHEMICAL IND LTD and othersPCT03-07-1997Inventive StepP000104057, P000104058View/Comment
GB2262229SANDOZ LTD [CH] UK Patent Office16-06-1993Inventive StepP000104057, P000104058View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top